Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies
Related Experiment Video
Updated: May 3, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Bing Ma1, Guangcong Liu2, Xin Chen1
1Department of Clinical Epidemiology, and Center of Evidence Based Medicine, The First Affiliated Hospital, China Medical University, Shenyang, China.
Insights
Patent foramen ovale (PFO) may be linked to cryptogenic stroke (CS), but observational data show conflicting results. Case-control studies suggest a strong association, while cohort studies do not, indicating more research is needed.
Area of Science:
- Cardiology
- Neurology
- Medical Research
Background:
- Patent foramen ovale (PFO) is a debated risk factor for cryptogenic stroke (CS).
- Previous randomized controlled trials have yielded inconsistent results regarding the PFO-stroke association.
- Observational data are re-evaluated to clarify the relationship between PFO and stroke.
Purpose of the Study:
- To reassess the association between PFO and stroke using observational studies.
- To synthesize evidence from case-control and cohort studies via meta-analysis.
- To investigate factors influencing the observed association.
Main Methods:
- Systematic electronic search of PubMed, Web of Science, and CNKI databases.
- Inclusion of case-control and cohort studies in English or Chinese.
- Random-effects meta-analysis to assess the PFO-stroke link.
Main Results:
- Case-control studies indicated a significant association between PFO and CS (OR: 2.94).
- Cohort studies did not demonstrate a significant association (HR: 1.28).
- Subgroup analyses showed varied results based on region, confounder adjustment, study quality, and diagnostic methods.
Conclusions:
- While case-control studies suggest a positive PFO-stroke effect, cohort study results challenge this.
- The credibility of PFO as a cause of stroke remains uncertain.
- Further clinical trial data are required to definitively confirm the effect of PFO on stroke.
Background:
Although patent foramen ovale (PFO) is considered to be associated with cryptogenic stroke (CS), there remains an ongoing disputation on this issue because of unstable results from randomized controlled trials. The aim of this study was to reassess the PFO effect on stroke through observational data.
Methods:
An electronic search of PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) were finished. Only case-control studies and cohort studies in Chinese or English were included in the analysis. Then random-effected meta-analysis models were performed to assess the association between PFO and stroke.
Results:
Twelve case-control studies and 6 cohort studies were eligible. Case-control studies showed strong association between PFO and CS (odds ratio [OR]: 2.94, 95% confidence interval [CI]: 2.06, 4.20; P < .001), but cohort studies failed to demonstrate a significant association (hazard ratio [HR]: 1.28, 95% CI: .91, 1.80; P = .155). Subgroup analysis revealed that the pooled OR decreased significantly when the region was limited to the United States (OR: 1.52, 95% CI: 1.00, 2.32; P = .083). OR of studies that adjusted major confounders was 1.74 (95% CI: 1.22, 2.47; P = .119) and high-quality studies was 1.68 (95% CI: 1.14, 2.47; P = .072). For cohort studies, a weak statistical association was observed in using transesophageal echocardiography (TEE) studies (HR: 1.45, 95% CI: 1.06, 2.01; P = .138) and follow-up years less than 4 years' studies (HR: 1.45, 95% CI: 1.00, 2.09; P = .064).
Conclusions:
Although case-control studies still show a positive effect of PFO on stroke, the results of cohort challenged the credibility. Further trial data are needed to confirm the effect of PFO on stroke.
More Related Videos
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

